# Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication

> **NCT00287027** · — · TERMINATED · sponsor: **National Alliance on Mental Illness New Hampshire** · enrollment: 60 (—)

## Conditions studied

- Psychotic Disorders

## Interventions

- **DRUG:** Risperdal Long Acting Injectable Antipsychotic Medication

## Key facts

- **NCT ID:** NCT00287027
- **Lead sponsor:** National Alliance on Mental Illness New Hampshire
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 60 (—)
- **Last updated:** 2007-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00287027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00287027, "Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT00287027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*